Zyomyx Pockets $27M in Series E Round

Jul 30, 2002

NEW YORK, July 30 - Zyomyx said today it has pocketed $27 million in a Series E round of private-equity financing.

Investors included existing group Credit Suisse First Boston Private Equity and newcomers Lilly BioVentures and GE Life Science and Technology Finance.

Zyomyx said the cash will go to help ramp up and launch its human cytokine protein-profiling biochip, due in early 2003.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Penguins With Roving Eyes

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Funding Lost

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

This Week in Science

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

New Framework Suggested

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

Main menu